PTGS2 and malignant colon neoplasm: Colon cancer cells treated with selective cyclooxygenase-2 inhibitors show lowered KIAA1199 expression [21], while high levels of KIAA1199 mRNA are positively correlated with cell mortality in human fibroblasts [22].